Position in ZTS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$180,368
-$115,984 QoQ
Shares Held
2,510
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,069
of 1,415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $2,658,245 across 7 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
34,881 | $1,181,768 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
6,015 | $667,304 | |
| 3 | ALKS |
Alkermes plc.
|
5,811 | $304,496 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
2,510 | $180,368 | |
| 5 | TRLV |
Trulieve Cannabis Corp.
|
16,592 | $163,099 | |
| 6 | LQDA |
Liquidia Corp
|
1,300 | $103,649 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
12,820 | $57,561 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $180,368 | 2,510 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $296,352 | 2,507 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $322,350 | 2,562 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $366,677 | 2,506 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $390,186 | 2,502 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $437,475 | 2,657 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $446,916 | 2,743 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $530,456 | 2,715 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $470,672 | 2,715 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $455,851 | 2,694 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $539,806 | 2,735 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $477,053 | 2,742 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $440,857 | 2,560 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $471,025 | 2,830 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $398,616 | 2,720 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $415,805 | 2,804 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $457,571 | 2,662 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $505,609 | 2,681 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $661,809 | 2,712 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $526,507 | 2,712 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $507,271 | 2,722 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $426,455 | 2,708 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $448,174 | 2,708 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $469,154 | 2,837 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $388,645 | 2,836 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $276,218 | 2,347 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||